APRISO IS A ONCE-DAILY 5-ASA PROVEN TO MAINTAIN ULCERATIVE COLITIS (UC) REMISSION IN ADULTS FOR UP TO 6 MONTHS1
APRISO features INTELLICOR® delayed- and extended-release delivery designed to provide locally acting coverage in the colon.1
The recommended daily dosage is 4 APRISO 0.375-g capsules taken once daily (1.5 g/day) in the morning with or without food to help your patients maintain remission.1
- In clinical studies, ~7 of 10 patients in the intent-to-treat population maintained remission for up to 6 months—compared with ~5.5 of 10 patients on placebo
- Caution should be exercised when administering APRISO to patients with liver disease, known renal dysfunction or a history of renal disease
- The most common adverse events were headache, diarrhea, upper abdominal pain, nausea, nasopharyngitis, influenza and influenza‐like illness, and sinusitis